However, while mutations in BMPR2 are a risk factor for PAH, incomplete penetrance (only ≈20% of carriers develop the disease)8 suggests that at least one additional genetic or environmental modifier (‘2nd hit’) appears necessary to trigger the pathophysiological changes leading to the development of PAH. Here, BMPR2 is linked to pulmonary arterial hypertension.